KawaguchiY., KawanishiH., MujaisS., TopleyN., OreopoulosD.G.Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Perit Dial Int2000; 20(Suppl 4): S43–55.
KawanishiH., MoriishiM., IdeK., DohiK.Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis.Perit Dial Int2008; 28(Suppl 3): S205–10.
4.
SummersA.M., BrenchleyP.E.An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now.Perit Dial Int2006; 26: 559–63.
BalasubramaniamG., BrownE.A., DavenportA., CairnsH., CooperB., FanS.L.The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.Nephrol Dial Transplant2009; 24: 3209–15.
7.
BrownM.C., SimpsonK., KerssensJ.J., MactierR.A.Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.Clin J Am Soc Nephrol2009; 4: 1222–9.
8.
KorteM.R., BoeschotenE.W., BetjesM.G.The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis.Neth J Med2009; 67: 359–62.
9.
TopleyN.Encapsulating peritoneal sclerosis: time to act.Perit Dial Int2006; 26: 564–5.
AlscherD.M., ReimoldF.New facts about encapsulating peritoneal sclerosis as a sequel of long-term peritoneal dialysis—what can we do?Minerva Urol Nefrol2007; 59: 269–79.
BraunN., AlscherD.M., FritzP., EdenhoferI., KimmelM., GaspertA.Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis.Nephrol Dial Transplant2011; 26: 1033–41.
14.
de FreitasD., JordaanA., BrenchleyP.E.C., HurstH., AugustineT., HutchisonA.Encapsulating peritoneal sclerosis (EPS) following renal transplantation (Abstract).Perit Dial Int2006; 26(Suppl 2): S116.
15.
FierenM.W., BetjesM.G., KorteM.R., BoerW.H.Posttransplant encapsulating peritoneal sclerosis: a worrying new trend?Perit Dial Int2007; 27: 619–24.
16.
KorteM.R., YoM., BetjesM.G., FierenM.W., van SaaseJ.C., BoerW.H.Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation.Nephrol Dial Transplant2007; 22: 2412–14.
DumanS., BozkurtD., SipahiS., SezakM., OzkanS., ErtilavM.Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.Adv Perit Dial2008; 24: 104–10.
19.
TempleS., ZaltzmanJ., PerlJ.Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy.Perit Dial Int2010; 30: 475–7.
